Comments

Neurocrine Biosciences (NBIX) Stock Price, Quote, News & History

NBIXNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$141.90

0.200.14%

Last update: Dec 18, 11:19 AM

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$141.78

Close

-

Volume / Avg.

197.55K / 988.78K

Day Range

$141.23 - $142.51

52 Wk Range

84.23 - 160.18

Market Cap

$14.15B

P/E Ratio

33.84

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

5.33%

Days to Cover

4.02

Recent Neurocrine Biosciences Inc News

Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile

Neurocrine's Phase 2 trial of NBI-1070770 in major depressive disorder missed its main goal but showed good safety and strong Q3 financial results.

Vandana Singh

Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday?

A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelled the S&P 500 above the 6,900 mark and lifted the Nasdaq 100 to 26,100 points, both breaking new records, as investors brace for the Federal Reserve's

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

3

Sep

10

Oct

2

Nov

4

1

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$141.78

Close

-

Volume / Avg.

197.55K / 988.78K

Day Range

$141.23 - $142.51

52 Wk Range

84.23 - 160.18

Market Cap

$14.15B

P/E Ratio

33.84

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

5.33%

Days to Cover

4.02

About

Sector

Health Care

Industry

Biotechnology

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

Show More

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Neurocrine Biosciences (NBIX) stock?

A

You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Neurocrine Biosciences (NBIX) competitors?

A

Other companies in Neurocrine Biosciences’s space includes: Exact Sciences Corp (NASDAQ:EXAS), BeOne Medicines Ltd (NASDAQ:ONC), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Roivant Sciences Ltd (NASDAQ:ROIV) and Amgen Inc (NASDAQ:AMGN).

Q

What is the forecast, or price target, for Neurocrine Biosciences (NBIX) stock?

A

Neurocrine Biosciences has a consensus price target of $176.15.

Q

What is the current price for Neurocrine Biosciences (NBIX)?

A

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $141.895 last updated December 18, 2025 at 11:19 AM EST.

Q

Does Neurocrine Biosciences (NBIX) pay a dividend?

A

There are no upcoming dividends for Neurocrine Biosciences.

Q

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

A

Neurocrine Biosciences does not have any upcoming earnings scheduled.

Q

Is Neurocrine Biosciences (NBIX) going to split?

A

There is no upcoming split for Neurocrine Biosciences.

Q

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

A

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Exact Sciences Corp

BeOne Medicines Ltd

Ionis Pharmaceuticals Inc

Roivant Sciences Ltd

United Therapeutics Corp